Upload
nguyendung
View
221
Download
0
Embed Size (px)
Citation preview
© FIMM - Institiute for Molecular Medicine Finland www.fimm.fi
dd.mm.yyyy
Introduction to
Clinical Metabolomics
Vidya Velagapudi, Ph.D, Adjunct Professor
Head of the Metabolomics Unit, Tech Centre,
Institute for Molecular Medicine Finland FIMM,
Helsinki, Finland
10/10/12
TransMed Course: Basics in Clinical Proteomics and
Metabolomics. Oct 10-19, 2012
© FIMM - Institiute for Molecular Medicine Finland www.fimm.fi
FIMM Technology Centre
Metabolomics Unit Core Facility
Biomedicum 2U, 2nd Floor
Services: Targeted quantitative high-
throughput metabolomics Analyses
for medical applications
E-mail: [email protected]
dd.mm.yyyy
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 3 dd.mm.yyyy 3
Metabolomics Unit
Waters XEVO-TQS triple quadrupole Hamilton star liquid handling system
Launched in 2011
Facility up and running in 2012
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 4
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 5
• Metabolites are bio-active small molecules involved in the
biochemical network
• Metabolome represents the collection of all metabolites in a
given biological sample
• Metabolomics is the systematic identification and quantitation
of the metabolites
• Clinical Applications include studies of chronic diseases,
pharmacology, pre-clinical drug trials, toxicology, transplant
monitoring, newborn screening and clinical chemistry.
What is Metabolomics?
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 6
6
Brief historical note
1500-2000BC
China
•Ants used to
detect patients
with diabetes
1940s-1970s
•Advances in analytics
•Pattern recognition
Metabolic profiling
21st century
•Advances in analytics
•Biostatistics & Bioinformatics
Modern era of metabolomics
and systems biology
Metabolomics is not new
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 7
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 8 Presentation name or name of the guest dd.mm.yyyy 8
Functional readout
Why Metabolomics ?
- End point of cellular regulation
- Dynamic & time sensitive
- Sensitivity
- High throughput
- Suitable platform for sys bio
- Integrated studies
( Metabolomics + GWAS,
Metabolomics + transcriptomics)
Gate to personalised medicine
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 9
Why is metabolomics necessary?
The proteome cannot be completely predicted from the
transcriptome due to some differences in regulatory
mechanisms.
The metabolome is further down the line from gene
function and so reflects more closely the activities of a
cell at the functional level.
A metabolite may come from more than one metabolic
pathway and it is only when you conduct a study on the
metabolome as a whole that you can identify which
pathways are involved in it’s metabolism.
Metabolomics can be viewed as complementary to
transcriptomics and proteomics.
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 10
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 11
H2N
O
OH
Glycine
NH2
NH
O
OH
Tryptophan
NH2
HN
NH
H2N
O
OH
Arginine
OHHO
ONN
H2N
N
N
PO
O
OH
O
P
O
OH
O
PO
OH
OH
Adenosine-5'-triphosphate
O
O
OH
Pyruvic acid
O
OH
O
HO
Succinic acid
O
O
HO
O
OH
Oxaloacetic acidAcetyl CoA
Structural Diversity of Metabolites
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 12
12
Metabolome
Homeostasis
‘Housekeeping’
Organic Acids
Lipids
Amino Acids
Nucleotides
Steroids
Eicosanoids
Neurotransmitters
Peptides
Trace elements
nM (10-9)
pM (10-12)
mM (10-3)
µM (10-6)
NMR
Mass
Spectrometry
CUSTOM
Biofluid metabolic profile = Phenotype Adapted from Sumner, LW, et al., Phytochem, 62, 817,2003
fM (10-15)
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 13
Successful extraction of metabolites from cellular
matrices is dependent upon the type extraction procedure.
When you have a structural diverse group of compounds,
it becomes difficult to develop methods that can separate
them all.
Ionization/Visualization of all metabolites is also difficult
to achieve, as each compound will vary in its affinity for a
detector.
Challenges in Metabolomics
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 14
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 15
Metabolomics platform
Meta
bolic
Pro
file
Global profiling
High Concentration
NMR profile
LCMS derivatized
(GCx)GCMS-profile
Target Biomarker
Assays (Multiplex) Immunoassays
GC, HPLC
Class-targeted
profiling
Bile acids, steroids,
fatty acids,
oxylipids
LC-FTMS
peptides
LCMS
Nucleosides,
Acyl CoA,
phosphorylated
LCMS
Glycerolipids,
Sphingomyelins,
Ceramides &
Cerebrosides
LCMS
fatty acids
GCMS
Endocannabinoids LCMS
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 16
Global analysis
An analysis of the total detectable content of the
sample (e.g. MS/NMR spectrum of serum/urine)
Primarily used for the detection of novel entities
• Q-ToF/MS
• GCxGC-ToF/MS
Targeted analysis
An analysis focused onto a specific molecule or
molecules (e.g. measurement of a specific m/z)
Used for the measurement of known variables for a
model
• Triple quadrupole MS
Metabolomics Analyses
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 17
Common mass spectrometers
GC-TOF
LC-ion trap–FT-ICR LC-ion trap
GCxGC-TOF
UPLC-Q-TOF
Triple quadrupole
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 18 18
Metabolomics_systems biology
Sensitivity
Small changes in activities of individual enzymes lead to small
changes in metabolic fluxes, but can lead to large changes in
metabolite concentrations
Throughput
The metabolomics platforms afford higher throughput than
current transcriptomics or proteomics technologies
Cellular
pathway
models
SYSTEMS
BIOLOGY
Clinical
studies Cells Organisms
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 19
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 20 20
Metabolomics work flow
Experiment design + Analytical chemistry + Chemometrics + Bioinformatics
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 21
Metabolite extraction
Extraction protocols differ based on the type of sample
• Serum/plasma
• Tissues
• Cells
• Urine
• CSF
• Saliva
• Dried blood spots
And the type of analysis
• Polar metabolites
• Non-polar metabolites
There is NO single extraction method that
could extract all the metabolites
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 22
Metabolite Separation
Different techniques are available based on the type of analysis
Liquid chromatography
Suitable for compounds that are non-volatile in nature
• HPLC
• UPLC
• Nano-LC
• 2D-LC
Gas chromatography
Suitable for compounds that are volatile in nature
• GC
• 2D-GC
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 23
Acquiring a Mass Spectrum
Inlet
Ionization
Mass Analyzer
Mass Sorting (filtering)
Ion
Detector
Detection
Ion
Source
• Liquid
• Vapor
Detect ions Form ions
(charged molecules) Sort Ions by Mass (m/z)
1330 1340 1350
100
75
50
25
0
Mass Spectrum
The separation of ions based on
their mass / charge ratio’
MS types: quadrupole, triple quad, TOF, quad-TOF, ion trap, ICR
All compounds must be ionized prior to MS detection!
Metabolite analysis
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 24 24
Separation
RPLC/CapLC +ESI
Mass
spectrometer
(Qtof)
10.00 15.00 20.00 25.00
Time 0
100
%
Retention time
MS-only ion chromatogram
400 600 800 1000 1200 1400 m/z 0
100
%
Mass /charge
862 863 864 865 866 867 868 869 m/z 0
100
%
864.43
863.04 862.70
864.92
865.41
865.92
866.44 867.42
869.45 868.34
Selected
Ion
MS survey scan
400 600 800 1000 1200 1400 1600 1800 2000 m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100 1047.5
1683.6 960.4
1160.5
1659.5
873.4 1273.6 1570.4
1531.6 646.4 1402.6 745.5 1771.3 1071.3 1199.5
1985.5 826.3 1857.9 610.1 647.3 545.3 425.9
b 14
b 7 b 9 b 10 b 11
b 12
b 13
b 15 b 17 b 16
y 8
y 15
y 14
y 13 y 12
y 11
y 10
y 9
y 7
y 6 y 5
1328.6
y 16
Mass / Charge
MS/MS fragmentation pattern
Sample
extract
ISs
Metabolites
LC/MS metabolomics platform
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 25
Data processing
25
MZmine 2
1. Platform independent (e.g. Windows, Linux, Mac)
2. Modular software design (easy to join development effort)
(http://mzmine.sourceforge.net/)
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 26
Data Analysis
Analysis of Variance
(ANOVA) Selection of peaks displaying significant changes
between Wild Type and Transgenic, separately from
gender or age specific effects
Univariate Analysis
Parametric
Tests (t-test)
Non-parametric
Tests (Kolmogorov-Smirnov)
Pre-processing & Normalization & QC
Prioritization of Important Peaks for Identification
Correlation Analysis
Correlation Networks Linear and Non-Linear approach
to profile association calculation
Select peaks with high
Level of correlations to
Strongest outliers
Exploratory Analysis
PCA and
Discriminant Analysis
Study general trends
In data
Verification of Metabolite IDs. Databases Extensions
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 27
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics Work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 28
Clinical Metabolomics Applications
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 29
> 95% of all diagnostic clinical assays look for small molecules
89% of known drugs are small molecules
50% of all drugs are derived from pre-existing metabolites
30% of identified genetic disorders involve diseases of small
molecule metabolism
Monitor/measure metabolite flux, consequences from gene
KOs, and enzyme or pathway kinetics
Clinical Metabolomics Applications
Goldsmith, P., et al., J Surg Res, 2010. 160(1), 122-32.
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 30
Clinical Metabolomics Applications
Generate metabolic “signatures” for disease states or host
responses
Obtain a more “holistic” view of metabolism (and treatment)
Accelerate assessment & diagnosis
More rapidly and accurately (and cheaply) assess/identify
disease phenotypes and functions of unknown genes
Monitor gene/environment interactions
Rapidly track effects from toxins/drugs/surgery
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 31
Metabolomics : Future?
› Metabolomics is one out of 14 fields
› Other fields in Nature‘s 2020 vision in which
metabolomics plays/can play a major role
’Personalized Medicine‘,
’Microbiome‘,
’Drug Discovery‘,
’Mental Health‘.
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 32
Outline
What is metabolomics?
Why metabolomics?
Challenges in metabolomics
Metabolomics platforms
Metabolomics Work flow
Applications of metabolomics
Small test
www.fimm.fi Presentation name or name of the guest dd.mm.yyyy 33
Small assignment
1. What is metabolomics?
2. What is the biggest challenge in metabolomics?
3. What are different metabolomics platforms?
4. What is the typical metabolomics work flow?
5. What are the clinical applications of metabolomics?